Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine Deacetylase (LpxC)
- Target
- LpxC
- Molecular classification
- Enzyme, Metalloenzyme, Deacetylase
01
Overview
UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (LpxC) is a zinc-dependent metalloenzyme found in Gram-negative bacteria that catalyzes the committed step in lipid A biosynthesis by removing the acetyl group from UDP-3-O-(R)-3-hydroxymyristoyl-N-acetylglucosamine to produce UDP-3-O-(R)-hydroxymyristoyl-glucosamine and acetate. This reaction is essential for the formation of lipid A, which anchors lipopolysaccharide (LPS) to the outer membrane of Gram-negative bacteria. LpxC is a validated antibacterial target due to its essential role in bacterial cell viability and its absence in mammals. Inhibitors of LpxC disrupt lipid A synthesis, leading to bacterial cell death.
- Other names
- UDP-3-O-acyl-N-acetylglucosamine deacetylaseUDP-3-O-[3-hydroxymyristoyl]-N-acetylglucosamine deacetylaseUDP-3-O-N-acetylglucosamine deacetylase
02
Mechanism of action
Inhibition of LpxC, leading to disruption of lipid A biosynthesis
03
Biological functions
Lipid A biosynthesis
04
Disease associations
Infection
05
Safety considerations
Potential for broad-spectrum antibacterial activity impacting commensal bacteriaDevelopment of resistance
06
Interacting drugs
Hydroxamate-based LpxC inhibitors
Beyond the preview
Go deeper on UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine Deacetylase (LpxC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine Deacetylase (LpxC).